4th Quarter - Report

LIFESCAN, INC. for LIFESCAN INC

Firm
Client
Income
—
Expenses
$45,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

-H.R. 6331, "Medicare Improvements for Patients and Providers Act of 2008", regarding amendments to titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes. -Comparative Effectiveness: Potential legislation that would create a mechanism for the government to assess the merits of two comparable therapeutic agents.

LobbyistCovered position, as disclosed
JED PERRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6331 (110th)

Medical/Disease Research/Clinical Labs MED

H.R. 5629, "Pathways for Biosimilars Act", regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes. H.R. 5361, "To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices"; regarding all provisions.

LobbyistCovered position, as disclosed
JED PERRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5629 (110th), H.R. 5361 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.